amsterdam : DSM

September 29, 2011 02:21 ET

DSM renews EUR500 million credit facility

HEERLEN, NETHERLANDS--(Marketwire - Sep 29, 2011) -

Royal DSM, the global Life Sciences and Materials Sciences company, today announces that it has entered into a committed credit facility of EUR500 million with certain credit relationship banks. This facility replaces a previous facility of the same amount which was scheduled to expire in October 2012.

The unsecured credit facility of EUR500 million is for a minumum term of 5 years and a maximum term of 7 years. In addition to this credit facility, DSM has a committed credit facility of EUR400 million (maturing in April 2013) as well as a commercial-paper program amounting to EUR1,500 million. DSM will use the commercial-paper program to a total of not more than EUR900 million. The agreements for the committed credit facilities neither have financial convenants nor material adverse changes clauses. The credit facilities and commercial- paper program are fully undrawn.

DSM is rated A3 by Moody's and A by Standard & Poor's, both with a stable outlook.

DSM - Bright Science. Brighter Living.™

Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 22,000 employees deliver annual net sales of about EUR9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com

Press release-pdf: http://hugin.info/130663/R/1550710/477457.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: DSM N.V. via Thomson Reuters ONE


Contact Information

  • For more information:

    DSM Corporate Communications
    Herman Betten
    tel. +31 (0) 45 5782017
    fax +31 (0) 45 5740680
    e-mail Email Contact

    DSM Investor Relations
    Hans Vossen
    tel. +31 (0) 45 5782864
    fax +31 (0) 10 4590275
    e-mail Email Contact